Economic Burden of West Nile Virus Disease, Quebec, Canada, 2012–2013

The economic burden of West Nile virus (WNV) infection is not known for Canada. We sought to describe the direct and indirect costs of WNV infection in the province of Quebec, Canada, up to 2 years after onset of signs and symptoms. We conducted a retrospective cohort study that included WNV cases r...

Descripción completa

Detalles Bibliográficos
Autores principales: Ouhoummane, Najwa, Tchouaket, Eric, Lowe, Anne-Marie, Fortin, Ann, Kairy, Dahlia, Vibien, Anne, Kovitz-Lensch, Jessica, Tannenbaum, Terry-Nan, Milord, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759276/
https://www.ncbi.nlm.nih.gov/pubmed/31538563
http://dx.doi.org/10.3201/eid2510.181608
Descripción
Sumario:The economic burden of West Nile virus (WNV) infection is not known for Canada. We sought to describe the direct and indirect costs of WNV infection in the province of Quebec, Canada, up to 2 years after onset of signs and symptoms. We conducted a retrospective cohort study that included WNV cases reported during 2012 and 2013. For 90 persons infected with WNV, persons with encephalitis accounted for the largest proportion of total cost: a median cost of $21,332 per patient compared with $8,124 for West Nile meningitis (p = 0.0004) and $192 for West Nile fever (p<0.0001). When results were extrapolated to all reported WNV patients, the estimated total cost for 124 symptomatic cases was ≈$1.7 million for 2012 and that for 31 symptomatic cases was ≈$430,000 for 2013. Our study provides information for the government to make informed decisions regarding public health policies and infectious diseases prevention and control programs.

Ejemplares similares